chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient started to experience nausea, flushing, lightheadedness after receiving 2nd dose of Moderna COVID-19 vaccine.  Patient reports they did not experience these symptoms following the 1st dose of the vaccine four weeks prior.  At 8:20am:  161/77  O2 sat=99%  HR=86.  At 8:24am:  BP=160/79,  At 8:29:  nausea subsiding, continued lightheadedness.    At 8:32am, BP=164/88.  Patient clinically stable.  Feels better.  Patient released from clinic at 8:34am.
I experienced extreme body aches, that lead to pressure in my chest. That lead to me going to the ER on 04/15/2021 was diagnosed with inflammation of the chest. I had to be on crutches for a little bit because the inflammation traveled to my feet and legs. Also developed tendinitis.
Patient lost consciousness about 30 seconds after the vaccine was administered.  He was very pale and sweaty.  He regained consciousness with stimulation from his mother (a nurse practitioner) and then passed out again.  After about a minute he regained consciousness.  We asked his mother if she wanted us to call 911 and she said yes.  Our technician spoke to the 911 representative and they sent a team which arrived about 30 minutes later.  Patient slowly felt better and regained color in his face over about 20 minutes.  During that time we applied ice packs to neck and wrists.  His blood pressure was 110/72.  After the EMT team evaluated him, he declined transport and treatment and left with his mother because he felt much better.
Swelling, erythema, warmth left thigh. The left thigh became twice the size of other leg.
This spontaneous report as received from a pharmacist refers to a currently 72 year old male patient. The patient had no known allergies. On 14-NOV-2012 the patient was vaccinated with a dose of ZOSTAVAX (lot# unspecified), 0.65 ml, subcutaneously. On an unknown date the patient started experiencing fever blister and then developed doctor diagnosed shingles. The outcome of the events was reported as recovered/resolved on an unknown date. The patient came into pharmacy for medical attention. Additional information is not expected.
Itching on both hands. Swelling of throat=took BENADRYL. Follow-up 1/20/10 throat= no more itching, swelling reduced.
soreness near injection site for 24 hours post immunization; This is a spontaneous report received from a contactable consumer (Patient). A 25-years-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EL3247), Solution for injection, via an unspecified route of administration, administered in Arm Left on 09Feb2021 15:30 (at the age of 25-years-old) as single dose for covid-19 immunisation. Medical history was reported as none. The patient's concomitant medications were not reported. Patient had no known allergies. Patient did not receive any other vaccine within four weeks of COVID-vaccine. Patient did not receive any other medication with two weeks. Patient was not diagnosed with COVID-19 prior to vaccination she was not tested for COVID -19 since vaccination. Patient historic vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE for COVID-19 immunisation. On 09Feb2021, the patient experienced soreness near injection site for 24 hours post immunization. No treatment was received to treat adverse events. The event was recovered on an unspecified date in Feb2021.   Follow-up attempts completed. No further information expected.
Moderna COVID-19 Vaccine EUA At about 8 pm the day following my vaccination; I started to experience sharp needle-like pain at the site of injection (left arm).  It was brief.  Immediately following that pain, the fingers on my left hand went numb and I couldn't feel them -- particularly my pinky and ring fingers.  I could move my fingers but they were numb.  I did not have a fever. This lasted about 2 hours.  I iced the site of injection, kept my hand above my shoulder and massaged my fingers for the duration (about 2 hours).  When this first occurred my heart was racing -- but that might have been because it scared me.  I feel fine today.
Tinnitus left ear .After every Pfizer vaccine shot I've experienced tinnitus . After the third dose my booster tinnitus is much worse very lout in my left ear.
Patient presented to the office with right arm erythema, edema  and warmth from the Injection at 7:45am.  Symptoms started this  morning at injection site and traveled down to mid bicep are. I booked him an appointment at 10:30am to see one of our physicians. I marked the area to monitor if redness traveled. At 10:30 the redness had spread to the antecubital area and posterior at the tricep area. The area had some blistering as well. Patient was given prednisone taper and vaccine was added to allergy list.
R THIGH FROM NEAR SITE VAC DOWNWARD TO MID KNEE AP RED AND SWOLLEN AND WARM--C/W INFLAMMATION-CELLULITIS, PATIENT WAS PUT ON CEFDINIR SUSPENSION 125 mg/5 mL Suspension for Reconstitution (7 mg/kg/dose; wt: 18.65 kg) 5 mL PO twice daily; for 10 days AND WILL RECHECK IN OFFICE ON MONDAY 11/19/18.
Swelling/itching to L arm where vaccine was given, swelling/itching to L eye, confusion, general feeling of "something is not right," general weakness.
Varicella vaccine administered 6-10-16, localized redness on 6/11/16 and developed into cellulitis on 6/12/16 seen and treated in ER.
Received vaccine 3 PM on 8/16/21. Arm soreness persists, 12:15 AM 8/17/21 cold/numb/pins & needles starts in upper right arm and goes all the way down to fingertips on right arm. Went to ER around 1:30 AM 8/17/21. Doctor rules out allergic reaction. Doctor says likely injection pressing on nerve. 3:30 AM 8/17/21 leaves emergency room. 10:42 AM 8/17/21 arm soreness persists and numb/cold feeling as well.
Initially right after the shot I had a bad stomach ache and headache including  a big egg on my arm I felt very lethargic and could not do my regular activities like exercise I began to have pain in both legs and calves with cramps on October 18 2022 after waking up and brushing my teeth I had a major panic attack including the inability to breath I went to het help and passed out I was taken by ambulance to the hospital. I had a CT scan of my lungs and multiple embolisms were found in both the upper and lower cavities. It was both extremely painful and difficult to breath. I was given Heparin in the Hospital and was switched to Eliquis. I am still experiencing extreme fatigue and daily activities are very difficult to manage and I am still not near where I was.
Initial report received from a consumer's parent on 04 March 2011. A 15 month-old female patient with a history of asthma, received on 08 October 2010 an injection (route and site not reported) of FLUZONE, sanofi pasteur Inc. lot number U3581BA, an injection of TRIPEDIA, sanofi pasteur Inc. lot number U3470CA, an injection (route and site not reported) of ACTHIB, sanofi pasteur SA lot number E0833-1 and sanofi pasteur Inc. UH122AB, and injection (route and site not reported) of MMR, Merck lot number 0578Z. She had no known allergies and took no other medications. It was not reported if the patient had any illnesses at the time of vaccination. The mother reported that the patient in the past had "minor" fevers associated with childhood vaccine series. On 19 October 2010, the patient had a fever (temperature not reported) and vomited. On 20 October 2010, the mother found the patient in the bed with eyes open, lethargic, no muscle tone in arms and legs, drooling, unresponsive, no reaction to the mother, could not focus and could not talk. The patient had no fever on 20 October 2010. The patient was seen the Emergency Room (ER) and hospitalized for several days. The mother stated that the physician did not call this a seizure since a seizure was not witnessed by anyone. The diagnosis was possible restrictive airway disease. The outcome was reported as recovered. The report in this case is the same as case 2011-00987. Documents held by sender: None.
Patient was receiving vaccine and fainted immediately after needlestick.  Was lowered to the floor. Unconscious for approx. 10 seconds. regained consciousness, was alert and oriented within minutes of event. Vitals monitored, juice given, recovered in chair under observation.
1st dose 10 months ago, 2nd not yet; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received 10 months ago).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 26-Sep-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient received 1st dose of shingles vaccine 10 months ago.  The patient was asking for what should we do for re second vaccination. Additional Supportive Information: The follow up would not possible, as no contact details were available. Till the time of reporting, the patient did not receive the 2nd dose, which led to incomplete course of vaccination.
Pronounced joint and chest pain for 1 week after 1st dose. Mild headache for the first 3 days after dose 1. No treatment. Pt has recovered (so far).
3inch x 1.5inch area on upper left arm where I received flu shot. Was tender. When looked it was red, slightly raised rash and very warm to touch.
Administered some vaccine that were expired a week ago. It was kept in the fridge; Patients were administered an expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients were administered an expired vaccine) and PRODUCT STORAGE ERROR (Administered some vaccine that were expired a week ago. It was kept in the fridge) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033K21-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients were administered an expired vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administered some vaccine that were expired a week ago. It was kept in the fridge). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients were administered an expired vaccine) and PRODUCT STORAGE ERROR (Administered some vaccine that were expired a week ago. It was kept in the fridge) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Date the vial was initially stored in the refrigerator on 28-Feb-2022. No concomitant medication was reported.    No treatment information was reported.
Fever 102, chills, body aches, sore throat, sweating, weakness. Went to rapid care on 5/30/2010. Was given antibiotic prescription and injection.
This case was reported by a physician via call center representative and described the occurrence of injection site pain in a male patient who received SHINGIRX for prophylaxis. Concomitant products included ibuprofen. On 24th July 2018, the patient received the 1st dose of SHINGRIX. In July 2018, less than a week after receiving SHINGRIX, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved. It was unknown if the reporter considered the injection site pain to be related to SHINGRIX. Additional details were provided as follows: The physician reported for himself. The patient received the SHINGRIX vaccine in the right deltoid. The patient had pain at the injection site which lasted 2 to 3 days.
pt recvd vax; w/in 4 hrs following vax, pt devel macular rash, severe malaise, & fatigue;
This case was reported by a consumer via media and described the occurrence of allergic reaction in a male patient who received DTPa vaccine for prophylaxis. On an unknown date, the patient received the 1st dose of DTPa vaccine. On an unknown date, unknown after receiving DTPa vaccine, the patient experienced allergic reaction, learning disability and body temperature increased. On an unknown date, the outcome of the allergic reaction, learning disability and body temperature increased were unknown. It was unknown if the reporter considered the allergic reaction, learning disability and body temperature increased to be related to DTPa vaccine. Additional details were provided as follows: The patient was son of the reporter. Age at vaccination was not reported. The patient got his 1st DTP shot and had an allergic reaction to the Pertussis, body temperature of 106 degree F, severe academic learning disability. The reporter blamed himself/herself for this. Lab Comments: The body temperature was measured on an unknown date.
muscle soreness at injection site; This is a spontaneous report from a contactable consumer (patient). A 34-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in the left arm on 27Jan2021 at 14:00 (at the age of 34-years-old) (Lot Number: EL3247) as dose 1, single for COVID-19 immunisation. The patient medical history was not reported. Concomitant medications included ibuprofen (strength: 600 mg) and vitamin D3. The patient did not have COVID prior to vaccination and had not been tested for COVID post-vaccination. On 28Jan2021, the patient experienced muscle soreness at injection site. No treatment was received for the event. The outcome of the event recovered on 31Jan2021.  No follow-up attempts are needed. No further information is expected.
About the 8th day after a small raised/ warm red bump started around injection spot. It has continued to spread to another spot on my arm - same - I am using over the counter Tylenol, Benadryl cream and cortisone cream. Continues to spread and diarrhea on 3/28/2021
Redness and swelling at site.  Warm to touch.  Returned in 24 hours swollen left arm no redness underarm only at injection site.
Later that day I developed chills which became super intense and I could not get warm for nothing.  Pain started in the lower back which persisted to all over my body with sever bone, joint and muscle pain.  A few hours later the chills broke, I vomited and became extremely hot so hot to where nothing I did would allow me to cool off.  I may of had a fever but I couldnt get up to check so I am unsure of that.  For the next week I was so tired I could hardly function.
first dose of Bexsero on March 4th 2021 / for the second dose Trumemba was received instead on April 4th 2021; This case was reported by a other health professional via call center representative and described the occurrence of interchange of vaccine products in a 17-year-old female patient who received Men B NVS (Bexsero) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis and MENINGOCOCCAL B VACCINE (TRUMENBA) for prophylaxis.   On 4th March 2021, the patient received Bexsero and Bexsero Pre-Filled Syringe Device. On 4th April 2021, the patient received the 2nd dose of TRUMENBA. On 4th March 2021, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced interchange of vaccine products. On an unknown date, the outcome of the interchange of vaccine products was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: Medical assistant reported that, the patient received first dose of Bexsero vaccination on 4th March 2021 and second dose was received with Trumemba instead of Bexsero, which led to  interchange of vaccine products. No further information was provided. The vaccine administration facility is same as primary reporter. The reporter did not consented to follow up.
Extremely itchy chronic hives 14 days after receiving my booster shot. Will not go away.
Notified by indicated client had received a prior Moderna COVID-19 vaccination on 4/27/2021 which the client did not disclose and responded on the pre-vaccination screening tool that they had no received a previous COVID-19 vaccine, ever.   Janssen COVID-19 vaccination provided to the client on 5/5/21 with no reported issues.
Woke up with fever, chills and nauseated and proceeded to throw up.  Went back to bed and woke up at 10:00 AM and had projectile diarrhea and continued to have more diarrhea throughout the day.  Also have aches, pains, headache, fatigue.  Just rested and slept.
Severe vomiting? 10-15x to dehydration  (32 hours) Migraine  (48 hours) Severe body aches (72 hours) Cannot move neck / neck pain (3 months - still ongoing) Insomnia  (3 months - still ongoing) Severe pain in chest  (3 months - still ongoing) Ongoing tremors all over body  (3 months - still ongoing) Cannot drink any alcoholic beverage  without getting a rash all over my chest  (3 months - still ongoing) Emergency Room visit to evaluate for heart attack
Started a little bigger than 1/2 dollar, red, raised, sore, hard. Today at office light red rash, getting smaller, not hard. TX - BENADRYL SPRAY.
Narrative: COVID infection following COVID vaccine series 02/09, MODERNA, dose #1 0309, MODERNA, dose #2 08/22 pt cc: exposure: 08/23 COVID swab, result: detected 08/23 SARS-COV-2 Variant Sequencing result: pending 09/01 clinically resolved
Local hives and swelling at site of Varivax and Hep A vaccine, persisting swelling at site for 2 weeks.
Arm started swelling within five minutes. Arm was turning red, itchy and burned. Neck and chest started turning red, itchy and burning, then spread up left side of face. Started coughing, throat itched, was really dizzy. Nurse sat next to me with an Epi-Pen for a few hours.
24 hours post vaccination, patient had itchiness, redness, and pain at the vaccination site. Took some TYLENOL and it seemed to help.
This spontaneous report as received from a healthcare worker refers to a 73 year old female patient who is also physician. The patient was immunocompetent. On 07-NOV-2014 the patient was vaccinated with PNEUMOVAX 23 (lot # K008409, expiry date: 04-MAR-2016, 0.5 ml, intramuscular in the right arm). The reason for vaccination was reported that she was age-appropriate and so that she won't carry anything to her elderly mother. On 08-NOV-2014, the patient experienced injection site swelling and redness which was the size of a quarter on 08-NOV-2014 and had progressed to be the size of a baseball by 10-NOV-2014. No treatment was given for the events. Action taken with PNEUMOVAX 23 was not reported. The outcome of the events was reported as not recovered/not resolved. The causality was unknown. No additional information was provided. The reporter requested for lot check for PNEUMOVAX 23, lot # K008409, expiry date: 04-MAR-2016. She indicated that she is not comfortable using any more this lot # PNEUMOVAX 23, due to these two adverse events. This one of several reports received from the same reporter. Additional information has been requested.
PAIN IN ARM; TIREDNESS; This spontaneous report received from a patient via a company representative concerned a 77 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  2021, the subject experienced pain in arm. On 2021, the subject experienced tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from pain in arm, and tiredness on 2021. This report was non-serious.
Information has been received from a physician referring to a 66 years old female patient. The patient's medical history included pain management unspecified and other unspecified medical history. The patient had drug allergy to hydrocodone and TYLENOL. On 09-JUN-2015 the patient was vaccinated with PNEUMOVAX23 injection (lot # K020215, exp 15-MAY-2016) 0.5 ml, intramuscularly in the left shoulder. Concomitant therapies included tramadol hydrochloride, FLEXERIL, simvastatin(manufacturer unknown) and hydrochlorothiazide/lisinopril. The physician reported with adverse event: Patient came into the office today(10-JUN-2015) with a left arm reaction by 4 by 8 inch induration and swelling that went down into the left biceps area and wraps around in that direction. The site was hot to the touch too. Physician stated he thinks it was a cellulitis-like reaction, and normally his patients did not experience such an significant adverse event such as this one. Physician stated he had not yet determined what treatment he would initiate (no treatment given to the patient). No lab was performed. The outcome was reported as not recovered/not resolved. No product quality issue(PQC) was involved. Additional information has been requested.
Menactra vaccine was administered on July 17, 2007.  After this was administered, it was noted that the vaccine had expired on July 10, 2007.  CDC Info line was called and was told to repeat this invalid dose with a valid dose and to report this error to Vaers.
Initial and follow up information has been received from a physician concerning a 70 year old female radiologist who was vaccinated on 11/19/04 with a dose of pneumococcal 23v polysaccharide vaccine (lot # 650084/0605P; previously reported as 0573P). Subsequently, on an unspecified date, the patient developed cellulitis at the injection site described as a extremely bad local reaction with a high fever and severe redness the size of an orange. Follow up information also indicated that the patient developed severe induration, erythema, and swelling at the injection site followed by shaking chills, fever, and local cellulitis. There was no illness at the time of vaccination. It was reported that the patient was seen as an outpatient and was treated with an oral antibiotics. It was also reported that the patient recovered on an unspecified date. The reporter considered the patient's experiences to be an important medical event (OMIC). There was no product quality complaint involved. Additional information has been requested.
Pt received MMR vaccine on 7/6/07 and Varicella vaccine on 7/13/07. Varicella should have been given 4 wks after receiving MMR.
Patient was given second dose of Pfizer Covid Vaccine 9 days after first dose.  Parent had written that first dose was administered 3/10/2021. When data was to be entered into database was found that first dose was given 10/13/2021.  When parent was contacted approximately 3 hours after injection she reported patient had a slight headache.